How Is Pfizer's Stock Performance Compared to Other Pharmaceuticals Stocks?

Pfizer Inc. (PFE), headquartered in New York, discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. With a market cap of $149.8 billion, the company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and PFE perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the general drug manufacturers industry. PFE thrives on its strong product lineup, including popular vaccines and blockbuster drugs. With a commitment to research and development, Pfizer continues to invest in innovation, ensuring a steady stream of new products. International sales make up nearly half of its revenue, highlighting its global reach and competitive standing in the pharmaceutical industry.